Form 4: Director Sells ALHC Shares Under 10b5-1 Plan

Alignment Healthcare Director Joseph S. Konowiecki sold 25,000 shares of common stock for $18 per share under a pre-arranged 10b5-1 plan.

Summary

• Director Joseph S. Konowiecki of Alignment Healthcare, Inc. (ALHC) reported a transaction involving the sale of common stock.
• The transaction occurred on October 28, 2025, with 25,000 shares of common stock disposed of at a price of $18 per share.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on March 5, 2025.
• Following this reported transaction, Konowiecki beneficially owns 1,085,973 shares of Alignment Healthcare common stock.

Sentiment

Score: 5

Explanation: The sale of shares by a director, while significant in volume, was pre-planned under a Rule 10b5-1 plan. This mitigates the immediate negative signal typically associated with insider sales, as the decision was made in advance and not necessarily based on new, adverse information. It represents a reduction in insider ownership, which is generally viewed neutrally to slightly negatively.

Negatives

• Director Joseph S. Konowiecki disposed of 25,000 shares of common stock, reducing his direct ownership in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: A director's sale, even if pre-planned, could be interpreted by some investors as a slight negative signal regarding future stock performance, potentially leading to short-term price volatility or a re-evaluation of the company's prospects.

Key Dates

Recommendation

The director's sale of 25,000 shares, while a notable transaction, was executed under a pre-arranged 10b5-1 plan. This indicates the decision to sell was made well in advance and is not necessarily a reaction to recent company performance or a change in the director's immediate outlook. Therefore, it warrants a 'hold' recommendation, suggesting investors should monitor future insider activity and company fundamentals rather than reacting solely to this planned transaction.

Keywords

Alignment Healthcare, ALHC, Joseph S. Konowiecki, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Director Transaction